Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe Locations section was expanded with new sites across Maryland, Michigan, Brussels Capital, Liege, Ontario, Bavaria, North Holland, Daegu Gwang Yeogsi, Seoul Teugbyeolsi, Barcelona, and London. The page revision was updated to v3.3.3, and older location subsections were removed.SummaryDifference1.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 removed; this is a minor metadata change that does not affect study information, so to avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedPublications section wording updated to indicate PubMed publications are automatically filled from PubMed and may not be about the study; revision tag updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the generic government funding/operating status notice at the top of the page. All core study details and locations remain unchanged.SummaryDifference0.3%

- Check68 days agoChange DetectedNo significant changes detected between the old and new page states. Core details such as the study title, status, locations, and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check97 days agoChange DetectedMajor update to the page content: a government-operating status notice and a new version tag (v3.2.0) replacing v3.1.0; no changes to pricing or availability information.SummaryDifference1%

Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.